The latest closing stock price for Spyre Therapeutics as of February 21, 2025 is 21.29.
An investor who bought $1,000 worth of Spyre Therapeutics stock at the IPO in 2016 would have $-913 today, roughly -1 times their original investment - a -23.75% compound annual growth rate over 9 years.
The all-time high Spyre Therapeutics stock closing price was 299.75 on April 08, 2016.
The Spyre Therapeutics 52-week high stock price is 47.97, which is 125.3% above the current share price.
The Spyre Therapeutics 52-week low stock price is 20.25, which is 4.9% below the current share price.
The average Spyre Therapeutics stock price for the last 52 weeks is 29.86.
An investor who bought $1,000 worth of Spyre Therapeutics stock at the IPO in 2016 would have $-913 today, roughly -1 times their original investment - a -23.75% compound annual growth rate over 9 years.
The all-time high Spyre Therapeutics stock closing price was 299.75 on April 08, 2016.
The Spyre Therapeutics 52-week high stock price is 47.97, which is 125.3% above the current share price.
The Spyre Therapeutics 52-week low stock price is 20.25, which is 4.9% below the current share price.
The average Spyre Therapeutics stock price for the last 52 weeks is 29.86.